NO872966D0 - PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING PREPARATIONS. - Google Patents

PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING PREPARATIONS.

Info

Publication number: NO872966D0
Authority: NO; Norway
Prior art keywords: granulocyty; procedure; preparation; stimulating; preparations
Prior art date: 1986-07-18

Application number

NO872966A

Other languages

Norwegian (no)

Other versions

NO171828B (en

NO171828C (en

NO872966L (en

Inventor

Minoru Machida

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-07-18

Filing date

1987-07-16

Publication date

1987-07-16

1987-07-16 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

1987-07-16 Publication of NO872966D0 publication Critical patent/NO872966D0/en

1988-01-19 Publication of NO872966L publication Critical patent/NO872966L/en

1993-02-01 Publication of NO171828B publication Critical patent/NO171828B/en

1993-05-12 Publication of NO171828C publication Critical patent/NO171828C/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

NO872966A 1986-07-18 1987-07-16 PROCEDURE FOR THE PREPARATION OF A STABILIZED PHARMACEUTICAL PREPARATION CONTAINING A GRANULOCYTIC COLONY STIMULATING FACTOR NO171828C (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP16948686		1986-07-18
JP16948986		1986-07-18
JP16948886		1986-07-18
JP16948786		1986-07-18

Publications (4)

Publication Number	Publication Date
NO872966D0 true NO872966D0 (en)	1987-07-16
NO872966L NO872966L (en)	1988-01-19
NO171828B NO171828B (en)	1993-02-01
NO171828C NO171828C (en)	1993-05-12

Family

ID=27474266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO872966A NO171828C (en)	1986-07-18	1987-07-16	PROCEDURE FOR THE PREPARATION OF A STABILIZED PHARMACEUTICAL PREPARATION CONTAINING A GRANULOCYTIC COLONY STIMULATING FACTOR

Country Status (24)

Country	Link
KR (1)	KR930004597B1 (en)
CN (1)	CN1033738C (en)
AT (1)	AT402259B (en)
AU (1)	AU611856B2 (en)
BE (1)	BE1000253A3 (en)
CA (1)	CA1297007C (en)
CH (1)	CH671157A5 (en)
DE (1)	DE3723781C2 (en)
DK (1)	DK171308B1 (en)
ES (1)	ES2010226A6 (en)
FR (1)	FR2601591B1 (en)
GB (1)	GB2193631B (en)
GR (1)	GR871067B (en)
HK (1)	HK64893A (en)
HU (1)	HU198627B (en)
IE (1)	IE60290B1 (en)
IL (1)	IL83220A (en)
IT (1)	IT1218927B (en)
NL (1)	NL192917C (en)
NO (1)	NO171828C (en)
PT (1)	PT85343B (en)
SE (1)	SE503312C2 (en)
SG (1)	SG64393G (en)
YU (1)	YU47543B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4929442A (en) *	1986-09-26	1990-05-29	Exovir, Inc.	Compositions suitable for human topical application including a growth factor and/or related materials
US4847325A (en) *	1988-01-20	1989-07-11	Cetus Corporation	Conjugation of polymer to colony stimulating factor-1
NZ228285A (en) *	1988-03-11	1991-08-27	Teikoku Seiyaku Kk	Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
US5981485A (en)	1997-07-14	1999-11-09	Genentech, Inc.	Human growth hormone aqueous formulation
US6132763A (en) *	1988-10-20	2000-10-17	Polymasc Pharmaceuticals Plc	Liposomes
US5349052A (en) *	1988-10-20	1994-09-20	Royal Free Hospital School Of Medicine	Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
GB8824591D0 (en) *	1988-10-20	1988-11-23	Royal Free Hosp School Med	Fractionation process
US5104651A (en) *	1988-12-16	1992-04-14	Amgen Inc.	Stabilized hydrophobic protein formulations of g-csf
JP3249147B2 (en) *	1990-06-01	2002-01-21	キリン−アムジエン・インコーポレーテツド	Oral preparation containing bioactive protein
EP0459516A1 (en) *	1990-06-01	1991-12-04	Kirin-Amgen, Inc.	Oral dosage form of biologically active proteins
FR2686900B1 (en) *	1992-01-31	1995-07-21	Rhone Poulenc Rorer Sa	NOVEL POLYPEPTIDES HAVING GRANULOCYTE COLONY STIMULATION ACTIVITY, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2686899B1 (en)	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	NOVEL BIOLOGICALLY ACTIVE POLYPEPTIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2693907B1 (en) *	1992-07-23	1994-09-02	Rhone Poulenc Rorer Sa	A method of administering granulocyte colony stimulating factor solutions.
EP0582932A1 (en) *	1992-08-11	1994-02-16	F. Hoffmann-La Roche Ag	Therapeutic system for the parenteral administration of hematopoietic growth factors
DE4242863A1 (en) *	1992-12-18	1994-06-23	Boehringer Mannheim Gmbh	Stable lyophilized pharmaceutical preparations of G-CSF
DE4242919A1 (en) *	1992-12-18	1994-06-23	Boehringer Mannheim Gmbh	Process for the preparation of storage-stable aqueous pharmaceutical preparations of G-CSF
US20030053982A1 (en)	1994-09-26	2003-03-20	Kinstler Olaf B.	N-terminally chemically modified protein compositions and methods
US5824784A (en)	1994-10-12	1998-10-20	Amgen Inc.	N-terminally chemically modified protein compositions and methods
WO1996024369A1 (en) *	1995-02-06	1996-08-15	Genetics Institute, Inc.	Formulations for il-12
TW434020B (en) *	1995-03-15	2001-05-16	Kirin Brewery	Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions
TW434021B (en) *	1995-03-15	2001-05-16	Kirin Brewery	Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions
GB9526733D0 (en)	1995-12-30	1996-02-28	Delta Biotechnology Ltd	Fusion proteins
US20030190307A1 (en)	1996-12-24	2003-10-09	Biogen, Inc.	Stable liquid interferon formulations
EP1060746A4 (en) *	1998-03-06	2002-06-19	Chugai Pharmaceutical Co Ltd	Protein-free preparations
US6979442B1 (en) *	1998-08-17	2005-12-27	Pfizer Inc.	Stabilized protein compositions
US7253142B1 (en)	1999-09-08	2007-08-07	Chugai Seiyaku Kabushiki Kaisha	Protein solution preparation and method of stabilizing the same
DE60103940T2 (en)	2000-02-29	2005-07-28	Pfizer Products Inc., Groton	Stabilized granulocyte colony stimulating factor
WO2001064241A1 (en) *	2000-02-29	2001-09-07	Chugai Seiyaku Kabushiki Kaisha	Preparations stabilized over long time
CA2405550A1 (en)	2000-04-12	2001-10-25	Human Genome Sciences, Inc.	Albumin fusion proteins
US6946134B1 (en)	2000-04-12	2005-09-20	Human Genome Sciences, Inc.	Albumin fusion proteins
AU8260701A (en)	2000-09-01	2002-03-13	Chugai Pharmaceutical Co Ltd	Solution preparations stabilized over long time
US8435939B2 (en)	2000-09-05	2013-05-07	Biokine Therapeutics Ltd.	Polypeptide anti-HIV agent containing the same
US7507413B2 (en)	2001-04-12	2009-03-24	Human Genome Sciences, Inc.	Albumin fusion proteins
WO2003060071A2 (en)	2001-12-21	2003-07-24	Human Genome Sciences, Inc.	Albumin fusion proteins
US7423007B2 (en)	2002-08-27	2008-09-09	Biokine Therapeutics Ltd.	Cxcr4 antagonist and use thereof
CA2517310C (en)	2003-02-28	2015-11-24	Chugai Seiyaku Kabushiki Kaisha	Stabilized protein-containing formulations comprising a poloxamer
DE202006020194U1 (en)	2006-03-01	2007-12-06	Bioceuticals Arzneimittel Ag	G-CSF liquid formulation
EP2942059A1 (en)	2006-12-21	2015-11-11	Biokine Therapeutics LTD.	4f-benzoyl-tn14003 for use in the treatment of multiple myeloma
WO2010092571A2 (en)	2009-02-11	2010-08-19	Yeda Research And Development Co. Ltd.	Short beta-defensin-derived peptides
CA2787648C (en) *	2010-01-19	2014-10-07	Hanmi Science Co., Ltd.	Liquid formulations for long-acting g-csf conjugate
EP2399572A1 (en)	2010-06-22	2011-12-28	Sandoz AG	Long-term storage of non-glycosylated recombinant human G-CSF
US10682390B2 (en)	2015-07-16	2020-06-16	Biokine Therapeutics Ltd.	Compositions and methods for treating cancer
CN109310733A (en)	2016-02-23	2019-02-05	百欧林纳克斯有限公司	The method for treating acute myelogenous leukemia
WO2018138267A1 (en)	2017-01-27	2018-08-02	Cinfa Biotech S.L.	Method for determining the efficacy of a g-csf containing composition
US20210196568A1 (en) *	2018-05-21	2021-07-01	Chugai Seiyaku Kabushiki Kaisha	Lyophilized formulation sealed in glass container

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652636A1 (en) *	1976-11-19	1978-05-24	Hans Uwe Dr Rer Nat Wolf	Stabilising protein during separation, purification and storage - by adding amphiphilic cpds., esp. lipid(s), ionic and or nonionic detergents
SE451844B (en) *	1978-03-20	1987-11-02	Morinaga Milk Industry Co Ltd	GLYCOPROTEIN, PROCEDURE FOR PREPARING THEREOF AND THERAPEUTIC AGENTS INCLUDING THE GLYCOPROTEIN
US4609546A (en) *	1982-06-24	1986-09-02	Japan Chemical Research Co., Ltd.	Long-acting composition
JPS60228422A (en) *	1984-04-26	1985-11-13	Suntory Ltd	Stabilized preparation of physiologically active substance
JPS61227526A (en) *	1984-07-25	1986-10-09	Chugai Pharmaceut Co Ltd	Novel csf and method of collecting same
JPS6191131A (en) *	1984-10-09	1986-05-09	Chugai Pharmaceut Co Ltd	Method and composition for preventing adsorption of pharmaceutical
AU590543B2 (en) *	1985-02-05	1989-11-09	Albert Einstein College Of Medicine Of Yeshiva University	Purification of native colony stimulating factor-1
US4810643A (en) *	1985-08-23	1989-03-07	Kirin- Amgen Inc.	Production of pluripotent granulocyte colony-stimulating factor
JPH0618778B2 (en) *	1985-10-04	1994-03-16	中外製薬株式会社	Leukopenia treatment

1987
- 1987-07-08 GR GR871067A patent/GR871067B/en unknown
- 1987-07-10 IT IT67594/87A patent/IT1218927B/en active
- 1987-07-13 NL NL8701640A patent/NL192917C/en not_active IP Right Cessation
- 1987-07-14 AT AT0177587A patent/AT402259B/en not_active IP Right Cessation
- 1987-07-15 DK DK368387A patent/DK171308B1/en not_active IP Right Cessation
- 1987-07-15 BE BE8700787A patent/BE1000253A3/en not_active IP Right Cessation
- 1987-07-15 AU AU75665/87A patent/AU611856B2/en not_active Expired
- 1987-07-15 CA CA000542239A patent/CA1297007C/en not_active Expired - Lifetime
- 1987-07-16 CH CH2727/87A patent/CH671157A5/en not_active IP Right Cessation
- 1987-07-16 NO NO872966A patent/NO171828C/en not_active IP Right Cessation
- 1987-07-16 PT PT85343A patent/PT85343B/en unknown
- 1987-07-17 IL IL83220A patent/IL83220A/en not_active IP Right Cessation
- 1987-07-17 IE IE193387A patent/IE60290B1/en not_active IP Right Cessation
- 1987-07-17 DE DE3723781A patent/DE3723781C2/en not_active Expired - Lifetime
- 1987-07-17 FR FR878710156A patent/FR2601591B1/en not_active Expired - Lifetime
- 1987-07-17 YU YU134287A patent/YU47543B/en unknown
- 1987-07-17 GB GB8716904A patent/GB2193631B/en not_active Expired - Lifetime
- 1987-07-17 HU HU873268A patent/HU198627B/en unknown
- 1987-07-17 ES ES8702106A patent/ES2010226A6/en not_active Expired
- 1987-07-17 SE SE8702907A patent/SE503312C2/en not_active IP Right Cessation
- 1987-07-18 CN CN87104963A patent/CN1033738C/en not_active Expired - Lifetime
- 1987-07-18 KR KR1019870007804A patent/KR930004597B1/en not_active IP Right Cessation
1993
- 1993-05-18 SG SG64393A patent/SG64393G/en unknown
- 1993-07-08 HK HK648/93A patent/HK64893A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
IT8767594A0 (en)	1987-07-10
SE503312C2 (en)	1996-05-13
SE8702907L (en)	1988-01-19
NO171828B (en)	1993-02-01
KR880001297A (en)	1988-04-22
GB8716904D0 (en)	1987-08-26
FR2601591A1 (en)	1988-01-22
GB2193631B (en)	1990-11-21
ATA177587A (en)	1996-08-15
AU611856B2 (en)	1991-06-27
DK368387A (en)	1988-01-19
YU47543B (en)	1995-10-03
NO171828C (en)	1993-05-12
NO872966L (en)	1988-01-19
HU198627B (en)	1989-11-28
SG64393G (en)	1993-08-06
KR930004597B1 (en)	1993-06-01
NL192917B (en)	1998-01-05
FR2601591B1 (en)	1991-04-26
CA1297007C (en)	1992-03-10
DK171308B1 (en)	1996-09-02
PT85343A (en)	1987-08-01
AU7566587A (en)	1988-01-21
PT85343B (en)	1990-04-30
CN1033738C (en)	1997-01-08
DK368387D0 (en)	1987-07-15
IL83220A (en)	1993-01-31
GR871067B (en)	1987-11-19
NL192917C (en)	1998-05-07
GB2193631A (en)	1988-02-17
CN87104963A (en)	1988-02-24
CH671157A5 (en)	1989-08-15
IE60290B1 (en)	1994-06-29
AT402259B (en)	1997-03-25
IL83220A0 (en)	1987-12-31
YU134287A (en)	1989-06-30
BE1000253A3 (en)	1988-09-27
HUT44941A (en)	1988-05-30
IT1218927B (en)	1990-04-24
SE8702907D0 (en)	1987-07-17
DE3723781A1 (en)	1988-01-21
IE871933L (en)	1988-01-18
NL8701640A (en)	1988-02-16
DE3723781C2 (en)	1999-09-02
ES2010226A6 (en)	1989-11-01
HK64893A (en)	1993-07-16

Publication	Publication Date	Title
NO872966D0 (en)	1987-07-16	PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING PREPARATIONS.
NO875045L (en)	1988-06-06	PROCEDURE FOR THE PREPARATION OF TOPICAL PREPARATIONS FOR TREATMENT OF ACN.
NO875378L (en)	1988-06-24	PROCEDURE FOR THE PREPARATION OF GRANULOCYTY STIMULATING FACTOR (POLYPEPTID DERIVATIVES).
NO870579L (en)	1987-08-17	PROCEDURE FOR THE PREPARATION OF INDOLIZIN DERIVATIVES.
NO871266D0 (en)	1987-03-26	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHINAZOLINE DERIVATIVES.
NO154905C (en)	1987-01-14	PROCEDURE FOR THE PREPARATION OF PREPARATIONS FOR THE TREATMENT OF MELANOMES.
NO167392C (en)	1991-10-30	PROCEDURE FOR THE PREPARATION OF IMIDAZOPYRIDINES.
NO171006C (en)	1993-01-13	PROCEDURE FOR THE MANUFACTURING OF ANTI-ANXIOUS PREPARATIONS
NO870526L (en)	1987-08-13	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DICHLORANILIN DERIVATIVES.
NO874869L (en)	1988-05-25	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE RELATIONS.
NO874032D0 (en)	1987-09-25	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CATECHOLD DERIVATIVES.
NO872712D0 (en)	1987-06-29	PROCEDURE FOR THE PREPARATION OF CALCIUM PREPARATIONS.
NO874467D0 (en)	1987-10-26	PROCEDURE FOR THE PREPARATION OF 3-PYRROLIDINOLS.
NO872551D0 (en)	1987-06-18	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO875488D0 (en)	1987-12-30	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKANSULPHONANILIDE DERIVATIVES.
NO874200L (en)	1988-04-11	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO874268D0 (en)	1987-10-13	PROCEDURE FOR THE PREPARATION OF N-SUBSTITUTED PIPERAZINONS.
NO871759L (en)	1987-11-02	PROCEDURE FOR THE PREPARATION OF SUCRAL BATH PREPARATIONS.
NO873400D0 (en)	1987-08-13	PROCEDURE FOR THE PREPARATION OF SULPHIDE-FREE ALKALIVESE.
NO873423D0 (en)	1987-08-14	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO875359D0 (en)	1987-12-21	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO872233D0 (en)	1987-05-27	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS
NO168941C (en)	1992-04-29	PROCEDURE FOR THE PREPARATION OF MERCAPTOACYLPROLIN.
NO874199D0 (en)	1987-10-07	PROCEDURE FOR THE PREPARATION OF IMIDAZO-PYRIDINO DERIVATIVES.
NO871907D0 (en)	1987-05-07	PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKENAMIDE DERIVATIVES.

Legal Events

Date	Code	Title	Description
2007-08-27	MK1K	Patent expired